Skip to main content

Table 1 Patient and tumor characteristics

From: Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma

Characteristics

Value or No. of patients (%)

Age at diagnosis (years)

 

  Median (Range)

64 (20-91)

Gender

 

  Female

182(15.5)

  Male

992(84.5)

Race

 

  White

1028(87.6)

  Non-white

146(12.4)

BMI

 

  ≤25

285(24.3)

  >25

704(60.0)

  Not applicable

185(15.7)

KPS

 

   70

117(10.0)

  80-100

1057(90.0)

Heavy alcohol use history

250(21.3)

Smoking at diagnosis

248 (21.1)

   No

924(78.7)

   Yes

250(21.3)

Second malignancy

186(15.8)

Tumor location

 

  Proximal/ Middle

159(13.5)

  Distal

1015(86.5)

Tumor histology

 

  ADE

914(77.9)

  SCC

237(20.2)

  Others

23(1.9)

Tumor differentiation

 

  Well/ Moderate

517(44.0)

  Poor

644(54.9)

  Not applicable

13(1.1)

Tumor length (cm)

 

  Median(Range)

5(0.4-20.0)

Clinical stage

 

  I-II

432(36.8)

  III-IV

714(60.8)

  Not applicable

28(2.4)

Induction chemotherapy

468 (40.0)

Radiation modality

 

  3DCRT

469(39.9)

  IMRT/Proton

705(60.1)

   Surgery

560(47.7)

  1. KPS: Karnofsky performance scores; BMI: body mass index; ADE: adenocarcinoma; SCC: squamous cell carcinoma; 3DCRT: 3-dimensional conformal radiation; IMRT: intensity-modulated radiation.